$PNBK
PATRIOT NATIONAL BANCORP INC

2020 Q1 Form 10-Q Financial Statement

#000143774920012633 Filed on June 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1 2018 Q4
Revenue $10.72M $10.59M
YoY Change 1.29% 13.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $392.0K $389.0K $400.0K
YoY Change 0.77% 11.14% 17.65%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $4.399M $4.227M
YoY Change 4.07% 87.95%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.431M $491.0K $220.0K
YoY Change -391.45% -65.15% -80.0%
Income Tax -$359.0K $168.0K -$110.0K
% Of Pretax Income 34.22% -50.0%
Net Earnings -$1.072M $323.0K $330.0K
YoY Change -431.89% -69.67% -45.0%
Net Earnings / Revenue -10.0% 3.05%
Basic Earnings Per Share -$0.27 $0.08
Diluted Earnings Per Share -$0.27 $0.08 $84.40K
COMMON SHARES
Basic Shares Outstanding 3.931M 3.917M
Diluted Shares Outstanding 3.931M 3.917M

Balance Sheet

Concept 2020 Q1 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $101.9M $110.9M
YoY Change 12.29% 39.9%
Cash & Equivalents $52.16M $56.63M $66.44M
Short-Term Investments $45.24M $44.46M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $34.31M $35.34M $35.44M
YoY Change -2.9% -0.85% 0.22%
Goodwill $1.107M $1.107M $1.728M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.00M $10.40M $10.90M
YoY Change 15.38% -7.96% 4.81%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $999.6M $953.1M $951.7M
YoY Change 4.88% 9.5% 11.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $8.200M $7.800M $5.200M
YoY Change 5.13% 81.4% 40.54%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.200M $7.800M $5.200M
YoY Change 5.13% 81.4% 40.54%
LONG-TERM LIABILITIES
Long-Term Debt $30.90M $31.00M $31.00M
YoY Change -0.32% 45.54% 44.86%
Other Long-Term Liabilities $2.600M $1.900M $2.900M
YoY Change 36.84% 0.0% 3.57%
Total Long-Term Liabilities $33.50M $32.90M $33.90M
YoY Change 1.82% 41.81% 40.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.200M $7.800M $5.200M
Total Long-Term Liabilities $33.50M $32.90M $33.90M
Total Liabilities $935.0M $883.5M $882.4M
YoY Change 5.83% 10.05% 12.35%
SHAREHOLDERS EQUITY
Retained Earnings -$39.85M -$35.52M -$35.79M
YoY Change 12.19% -6.05% -7.83%
Common Stock $106.2M $107.2M $213.1M
YoY Change -0.9% 0.2% 99.27%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.179M $1.179M
YoY Change 0.0% 0.0%
Treasury Stock Shares $73.74K $73.74K
Shareholders Equity $64.62M $69.65M $69.34M
YoY Change
Total Liabilities & Shareholders Equity $999.6M $953.1M $951.7M
YoY Change 4.88% 9.5% 11.69%

Cashflow Statement

Concept 2020 Q1 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$1.072M $323.0K $330.0K
YoY Change -431.89% -69.67% -45.0%
Depreciation, Depletion And Amortization $392.0K $389.0K $400.0K
YoY Change 0.77% 11.14% 17.65%
Cash From Operating Activities -$4.313M $435.0K -$130.0K
YoY Change -1091.49% -74.03% -104.85%
INVESTING ACTIVITIES
Capital Expenditures $3.000K $9.000K $90.00K
YoY Change -66.67% -98.57% -150.0%
Acquisitions
YoY Change
Other Investing Activities -$5.520M -$8.680M -$18.45M
YoY Change -36.41% 68.87% 257.56%
Cash From Investing Activities -$5.520M -$8.688M -$18.36M
YoY Change -36.46% 50.52% 243.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 22.59M -1.552M 36.21M
YoY Change -1555.22% -109.21% 57.64%
NET CHANGE
Cash From Operating Activities -4.313M 435.0K -130.0K
Cash From Investing Activities -5.520M -8.688M -18.36M
Cash From Financing Activities 22.59M -1.552M 36.21M
Net Change In Cash 12.75M -9.805M 17.72M
YoY Change -230.06% -176.9% -12.75%
FREE CASH FLOW
Cash From Operating Activities -$4.313M $435.0K -$130.0K
Capital Expenditures $3.000K $9.000K $90.00K
Free Cash Flow -$4.316M $426.0K -$220.0K
YoY Change -1113.15% -59.23% -107.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
PATRIOT NATIONAL BANCORP INC
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Trading Symbol
TradingSymbol
pnbk
CY2020Q1 pnbk Accrued Interest And Dividends Receivable
AccruedInterestAndDividendsReceivable
3801000
CY2019Q4 pnbk Accrued Interest And Dividends Receivable
AccruedInterestAndDividendsReceivable
3603000
CY2020Q1 pnbk Amortization And Accretion Of Purchase Loan Premiums And Discounts Net
AmortizationAndAccretionOfPurchaseLoanPremiumsAndDiscountsNet
-190000
CY2019Q1 pnbk Amortization And Accretion Of Purchase Loan Premiums And Discounts Net
AmortizationAndAccretionOfPurchaseLoanPremiumsAndDiscountsNet
-174000
CY2020Q1 pnbk Amortization Of Servicing Assets Of Sold Loans
AmortizationOfServicingAssetsOfSoldLoans
204000
CY2019Q1 pnbk Amortization Of Servicing Assets Of Sold Loans
AmortizationOfServicingAssetsOfSoldLoans
4000
CY2020Q1 pnbk Availableforsale Securities Debt Maturities Year One Through Five Amortized Cost Basis
AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveAmortizedCostBasis
7504000
CY2019Q4 pnbk Availableforsale Securities Debt Maturities Year One Through Five Amortized Cost Basis
AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveAmortizedCostBasis
7823000
CY2020Q1 pnbk Availableforsale Securities Debt Maturities Year One Through Five Fair Value
AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveFairValue
7241000
CY2019Q4 pnbk Availableforsale Securities Debt Maturities Year One Through Five Fair Value
AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveFairValue
7961000
CY2020Q1 pnbk Banks Reserve Based On Analysis In Unfunded Commitments
BanksReserveBasedOnAnalysisInUnfundedCommitments
8000
CY2019Q4 pnbk Banks Reserve Based On Analysis In Unfunded Commitments
BanksReserveBasedOnAnalysisInUnfundedCommitments
8000
CY2020Q1 pnbk Capital Conservation Buffer
CapitalConservationBuffer
0.025
CY2020Q1 pnbk Capitalized Servicing Assets
CapitalizedServicingAssets
2000
CY2019Q1 pnbk Capitalized Servicing Assets
CapitalizedServicingAssets
66000
CY2020Q1 pnbk Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Other Changes
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldOtherChanges
45000
CY2019Q1 pnbk Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Other Changes
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldOtherChanges
573000
CY2020Q1 pnbk Certain Loans Acquired Individually Evaluated For Impairment
CertainLoansAcquiredIndividuallyEvaluatedForImpairment
38000
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001098146
CY2020Q1 pnbk Community Bank Tier One Leverage Ratio
CommunityBankTierOneLeverageRatio
0.09
CY2020Q1 pnbk Fees And Service Charges
FeesAndServiceCharges
114000
CY2019Q1 pnbk Fees And Service Charges
FeesAndServiceCharges
127000
CY2020Q1 pnbk Commitments To Extend Credit
CommitmentsToExtendCredit
142148000
CY2019Q4 pnbk Commitments To Extend Credit
CommitmentsToExtendCredit
145065000
CY2020Q1 pnbk Common Equity Tier1 Capital Required For Capital Adequacy To Risk Weighted Assets
CommonEquityTier1CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.065
CY2019Q1 pnbk Common Equity Tier1 Capital Required For Capital Adequacy To Risk Weighted Assets
CommonEquityTier1CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.07
CY2020Q1 pnbk Community Bank Tier One Leverage Capital Required For Capital Adequacy
CommunityBankTierOneLeverageCapitalRequiredForCapitalAdequacy
10000000000
CY2020Q1 pnbk Financing Receivable Principal And Interest Deferred Payments
FinancingReceivablePrincipalAndInterestDeferredPayments
5500000
CY2020Q1 pnbk Financing Receivable Troubled Debt Restructuring Number Of Contracts
FinancingReceivableTroubledDebtRestructuringNumberOfContracts
6
CY2019Q4 pnbk Financing Receivable Troubled Debt Restructuring Number Of Contracts
FinancingReceivableTroubledDebtRestructuringNumberOfContracts
6
CY2020Q1 pnbk Gain Loss On Sale Of Sba Loans Held For Sale Net
GainLossOnSaleOfSBALoansHeldForSaleNet
12000
CY2019Q1 pnbk Gain Loss On Sale Of Sba Loans Held For Sale Net
GainLossOnSaleOfSBALoansHeldForSaleNet
380000
CY2020Q1 pnbk General Insurance Income Expense
GeneralInsuranceIncomeExpense
70000
CY2019Q1 pnbk General Insurance Income Expense
GeneralInsuranceIncomeExpense
41000
CY2019Q1 pnbk Impact Of Adoption Of Accounting Standards Update
ImpactOfAdoptionOfAccountingStandardsUpdate
-11000
CY2020Q1 pnbk Impaired Financing Receivable Nonperforming Loans Discount Of Appraisal Value Selling Costs Percent
ImpairedFinancingReceivableNonperformingLoansDiscountOfAppraisalValueSellingCostsPercent
0.08
CY2019Q4 pnbk Impaired Financing Receivable Nonperforming Loans Discount Of Appraisal Value Selling Costs Percent
ImpairedFinancingReceivableNonperformingLoansDiscountOfAppraisalValueSellingCostsPercent
0.08
CY2020Q1 pnbk Impaired Financing Receivable Nonperforming Loans Discount To Appraisal Value Percent
ImpairedFinancingReceivableNonperformingLoansDiscountToAppraisalValuePercent
0.12
CY2019Q4 pnbk Impaired Financing Receivable Nonperforming Loans Discount To Appraisal Value Percent
ImpairedFinancingReceivableNonperformingLoansDiscountToAppraisalValuePercent
0.12
CY2020Q1 pnbk Interest Expense Notes Payable
InterestExpenseNotesPayable
5000
CY2019Q1 pnbk Interest Expense Notes Payable
InterestExpenseNotesPayable
6000
CY2020Q1 pnbk Interest Expense Senior Debt
InterestExpenseSeniorDebt
229000
CY2019Q1 pnbk Interest Expense Senior Debt
InterestExpenseSeniorDebt
229000
CY2020Q1 pnbk Loan Application Inspection Processing Fees
LoanApplicationInspectionProcessingFees
53000
CY2019Q1 pnbk Loan Application Inspection Processing Fees
LoanApplicationInspectionProcessingFees
14000
CY2020Q1 pnbk Loans Receivable Term To Reset To Fhlb Rate
LoansReceivableTermToResetToFhlbRate
P5Y
CY2020Q1 pnbk Loans Serviced By Entity But Owned By A Third Party
LoansServicedByEntityButOwnedByAThirdParty
13500000
CY2019Q4 pnbk Loans Serviced By Entity But Owned By A Third Party
LoansServicedByEntityButOwnedByAThirdParty
13600000
CY2020Q1 pnbk Material And Communications
MaterialAndCommunications
120000
CY2019Q1 pnbk Material And Communications
MaterialAndCommunications
134000
CY2020Q1 pnbk Maximum Period For Charged Off Of Consumer Installment Loans
MaximumPeriodForChargedOffOfConsumerInstallmentLoans
P180D
CY2020Q1 pnbk Maximum Period Of Credit Extension Of Construction Loans
MaximumPeriodOfCreditExtensionOfConstructionLoans
P1Y180D
CY2020Q1 pnbk Noncash Activity Increase In Operating Lease Liabilities
NoncashActivityIncreaseInOperatingLeaseLiabilities
57000
CY2019Q1 pnbk Noncash Activity Increase In Operating Lease Liabilities
NoncashActivityIncreaseInOperatingLeaseLiabilities
-3444000
CY2020Q1 pnbk Noncash Activity Increase In Operating Lease Rightofuse Assets
NoncashActivityIncreaseInOperatingLeaseRightofuseAssets
-57000
CY2019Q1 pnbk Noncash Activity Increase In Operating Lease Rightofuse Assets
NoncashActivityIncreaseInOperatingLeaseRightofuseAssets
3397000
CY2020Q1 pnbk Noncash Or Part Noncash Acquisition Contingent Liabilities Assumed
NoncashOrPartNoncashAcquisitionContingentLiabilitiesAssumed
CY2019Q1 pnbk Noncash Or Part Noncash Acquisition Contingent Liabilities Assumed
NoncashOrPartNoncashAcquisitionContingentLiabilitiesAssumed
621000
CY2020Q1 pnbk Number Of Availableforsale Securities
NumberOfAvailableforsaleSecurities
26
CY2019Q4 pnbk Number Of Availableforsale Securities
NumberOfAvailableforsaleSecurities
27
CY2020Q1 pnbk Number Of Impaired Loans
NumberOfImpairedLoans
26
CY2019Q4 pnbk Number Of Impaired Loans
NumberOfImpairedLoans
27
CY2020Q1 pnbk Payments For Origination Of Sba Loans Held For Sale
PaymentsForOriginationOfSBALoansHeldForSale
2566000
CY2019Q1 pnbk Payments For Origination Of Sba Loans Held For Sale
PaymentsForOriginationOfSBALoansHeldForSale
4908000
CY2020Q1 pnbk Period For Charged Off Of Closeend Credits
PeriodForChargedOffOfCloseendCredits
P120D
CY2020Q1 pnbk Period For Charged Off Of Openend Credits
PeriodForChargedOffOfOpenendCredits
P180D
CY2020Q1 pnbk Proceeds From Payments For Originated Loans Receivable Net
ProceedsFromPaymentsForOriginatedLoansReceivableNet
11873000
CY2019Q1 pnbk Proceeds From Payments For Originated Loans Receivable Net
ProceedsFromPaymentsForOriginatedLoansReceivableNet
-3481000
CY2020Q1 pnbk Proceeds From Principal Repayments On Debt Securities Available For Sale
ProceedsFromPrincipalRepaymentsOnDebtSecuritiesAvailableForSale
1635000
CY2019Q1 pnbk Proceeds From Principal Repayments On Debt Securities Available For Sale
ProceedsFromPrincipalRepaymentsOnDebtSecuritiesAvailableForSale
613000
CY2020Q1 pnbk Project Expenses
ProjectExpenses
94000
CY2019Q1 pnbk Project Expenses
ProjectExpenses
80000
CY2020Q1 pnbk Regulatory Assessments
RegulatoryAssessments
440000
CY2019Q1 pnbk Regulatory Assessments
RegulatoryAssessments
315000
CY2019Q1 pnbk Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets With Capital Buffer
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssetsWithCapitalBuffer
0.085
CY2020Q1 pnbk Time Deposits Below Fdic Insurance Limit
TimeDepositsBelowFDICInsuranceLimit
205311000
CY2019Q4 pnbk Time Deposits Below Fdic Insurance Limit
TimeDepositsBelowFDICInsuranceLimit
193942000
CY2020Q1 pnbk Unrealized Holding Losses Depreciation Percentage From Amortized Cost
UnrealizedHoldingLossesDepreciationPercentageFromAmortizedCost
0.093
CY2019Q4 pnbk Unrealized Holding Losses Depreciation Percentage From Amortized Cost
UnrealizedHoldingLossesDepreciationPercentageFromAmortizedCost
0.037
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-44000
CY2019Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
11000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1745000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-403000
CY2020Q1 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
2637000
CY2019Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
3681000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
10916000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
10115000
CY2020Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
41000
CY2019Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
49000
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
44000
CY2019Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
28000
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
28000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10112
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
448
CY2020Q1 us-gaap Assets
Assets
999579000
CY2019Q4 us-gaap Assets
Assets
979836000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
431000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
405000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2782000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
948000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
47181000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
48860000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
29745000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
30226000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
27407000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
29497000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
9932000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
10811000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
10182000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
10859000
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
44830000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48317000
CY2020Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font: inherit;">1.</div>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basis of Financial Statement Presentation</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The accompanying unaudited condensed consolidated financial statements of Patriot National Bancorp, Inc. (the&nbsp;&#x201c;Company&#x201d;) and its wholly-owned subsidiaries&nbsp;Patriot Bank, N.A. (the &#x201c;Bank&#x201d;), Patriot National Statutory Trust I and PinPat Acquisition Corporation (collectively, &#x201c;Patriot&#x201d;), have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;) have been omitted. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included on the Annual Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The consolidated balance sheet at <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019 </div>presented herein has been derived from the audited consolidated financial statements of the Company at that date, but does <div style="display: inline; font-style: italic; font: inherit;">not</div> include all of the information and footnotes required by US GAAP for complete financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and to disclose contingent assets and liabilities. Actual results could differ from those estimates. Management has identified accounting for the allowance for loan and lease losses, the analysis and valuation of its investment securities, the valuation of deferred tax assets, the impairment of goodwill, the valuation of derivatives, and the valuation of servicing assets as certain of the Company&#x2019;s more significant accounting policies and estimates, in that they are critical to the presentation of the Company&#x2019;s consolidated financial condition and results of operations. As they concern matters that are inherently uncertain, these estimates require management to make subjective and complex judgments in the preparation of the Company&#x2019;s consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Reclassifications:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Certain amounts appearing in the financial statements and notes thereto for prior periods have been reclassified to conform with the current presentation. The reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on net income or stockholders&#x2019; equity as previously reported.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The information furnished reflects, in the opinion of management, all normal recurring adjustments necessary for a fair presentation of the results for the interim periods presented. The results of operations for the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of the results of operations that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be expected for the remainder of <div style="display: inline; font-style: italic; font: inherit;">2020.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> Impact</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font: inherit;"> March 2020, </div>the World Health Organization declared novel coronavirus disease <div style="display: inline; font-style: italic; font: inherit;">2019</div> ("COVID-<div style="display: inline; font-style: italic; font: inherit;">19"</div>) as a global pandemic. The COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic has negatively impacted the global and U.S. economies. Many businesses in the U.S., including those in the markets we serve, were required to close, causing a significant increase in unemployment and loss of revenue for businesses that were required to close.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The consolidated financial statements reflect estimates and assumptions that affect the reported amounts of assets and liabilities, including the amount of the allowance for loan losses. The assumptions and estimates used in the financial statements were impacted by the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic. The COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic did have an adverse impact on our earnings and resulted in an increase to the provision for loan losses when compared to the same period in <div style="display: inline; font-style: italic; font: inherit;">2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We are unable to estimate the full impact of COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> on our business and operations at this time. The extent of such impact will depend on future developments, which are highly uncertain, including when COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> can be controlled and abated and when and how the economy <div style="display: inline; font-style: italic; font: inherit;"> may </div>be reopened. The pandemic could cause us to experience higher credit losses in our loan portfolio, impairment of our goodwill, reduced demand for our products and services, or other negative impacts on our financial position, results of operations, and prospects.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On <div style="display: inline; font-style: italic; font: inherit;"> March 27, 2020, </div>the President of the United States signed into law the Coronavirus Aid, Relief and Economic Security (&#x201c;CARES&#x201d;) Act in response to the coronavirus pandemic. This legislation aims at providing relief for individuals and businesses that have been negatively impacted by the coronavirus pandemic.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The CARES Act includes a provision for the Company to opt out of applying the &#x201c;troubled-debt restructuring&#x201d; (&#x201c;TDR&#x201d;) accounting guidance in ASC <div style="display: inline; font-style: italic; font: inherit;">310</div>-<div style="display: inline; font-style: italic; font: inherit;">40</div> for certain loan modifications. Loan modifications made between <div style="display: inline; font-style: italic; font: inherit;"> March 1, 2020 </div>and the earlier of i) <div style="display: inline; font-style: italic; font: inherit;"> December 30, 2020 </div>or ii) <div style="display: inline; font-style: italic; font: inherit;">60</div> days after the President declares a termination of the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> national emergency are eligible for this relief if the related loans were <div style="display: inline; font-style: italic; font: inherit;">not</div> more than <div style="display: inline; font-style: italic; font: inherit;">30</div> days past due as of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019. </div>The Company has assessed which loans qualify for this treatment. The CARES Act also permits the Bank to continue accrue interest on loans that have received deferral treatment as a result of the pandemic. In addition, on <div style="display: inline; font-style: italic; font: inherit;"> April 7, 2020, </div>a group of banking regulatory agencies issued a revised interagency statement that offers practical expedients for evaluating whether COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> loan modifications are TDRs.</div></div>
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
133000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
280000
CY2019Q1 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.105
CY2020Q1 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.1
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39404000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66437000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52156000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56632000
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12752000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9805000
CY2020Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
1806000
CY2019Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
2693000
CY2019Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
47000
CY2018Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
792000
CY2020Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
CY2019Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
194000
CY2020Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
2000
CY2019Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
25000
CY2020Q1 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Carrying Amount Net
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesCarryingAmountNet
38000
CY2019Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Carrying Amount Net
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesCarryingAmountNet
176000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4006582
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4004410
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3932841
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3930669
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
106213000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
106170000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2414000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
311000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
13341000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
17081000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2261000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
886000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
13937000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
7724000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
521000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
62000
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
27278000
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
24805000
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2782000
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
948000
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
16
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
15
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11989000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11133000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-390000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
497000
CY2020Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
89000
CY2019Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
54000
CY2020Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.5
CY2020Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2020Q1 us-gaap Deposits
Deposits
803214000
CY2019Q4 us-gaap Deposits
Deposits
769535000
CY2020Q1 us-gaap Deposits Domestic
DepositsDomestic
803214000
CY2019Q4 us-gaap Deposits Domestic
DepositsDomestic
769535000
CY2020Q1 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
132629000
CY2019Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
99115000
CY2020Q1 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
28265000
CY2019Q4 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
26864000
CY2020Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
59567000
CY2019Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
64020000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
392000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
389000
CY2020Q1 us-gaap Derivative Assets
DerivativeAssets
1295000
CY2019Q4 us-gaap Derivative Assets
DerivativeAssets
694000
CY2020Q1 us-gaap Deteriorated Loans Transferred In Debt Securities Accreditable Yield Period Increase Decrease
DeterioratedLoansTransferredInDebtSecuritiesAccreditableYieldPeriodIncreaseDecrease
2000
CY2019Q1 us-gaap Deteriorated Loans Transferred In Debt Securities Accreditable Yield Period Increase Decrease
DeterioratedLoansTransferredInDebtSecuritiesAccreditableYieldPeriodIncreaseDecrease
25000
CY2020Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
138000
CY2019Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
118000
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
39000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
18000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1179000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-479000
CY2020Q1 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-1044000
CY2019Q1 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-1004000
CY2019Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
4477000
CY2020Q1 us-gaap Federal Reserve Bank Stock
FederalReserveBankStock
2897000
CY2019Q4 us-gaap Federal Reserve Bank Stock
FederalReserveBankStock
2897000
CY2020Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
133000
CY2019Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
280000
CY2020Q1 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
90000000
CY2019Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
100000000
CY2020Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
4477000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
9200000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1716000
CY2020Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
800778000
CY2020Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
18025000
CY2020Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2019Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
1
CY2019Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
8800000
CY2019Q1 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
8800000
CY2020Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
10952000
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
10953000
CY2020Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
605000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
623000
CY2020Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
12000
CY2019Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
380000
CY2020Q1 us-gaap Goodwill
Goodwill
1107000
CY2019Q4 us-gaap Goodwill
Goodwill
1107000
CY2018Q4 us-gaap Goodwill
Goodwill
1728000
CY2019Q1 us-gaap Goodwill
Goodwill
1107000
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
CY2019Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-621000
CY2020Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
18865000
CY2019Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
24243000
CY2020Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
33000
CY2019Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
175000
CY2020Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
18000000
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
19600000
CY2020Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1700000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1500000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
9978000
CY2019Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
17798000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
29000
CY2019Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
175000
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
8887000
CY2019Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
6445000
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
4000
CY2019Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1431000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
491000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-359000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
168000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
3000
CY2020Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
33679000
CY2019Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
9540000
CY2020Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
198000
CY2019Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-145000
CY2020Q1 us-gaap Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
-10000000
CY2019Q1 us-gaap Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
-10000000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
763000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
866000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
390000
CY2019Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
370000
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10722000
CY2019Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10585000
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
10033000
CY2019Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
9755000
CY2020Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
719631000
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
681400000
CY2020Q1 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
719631000
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
681400000
CY2020Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
50350000
CY2019Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
36711000
CY2020Q1 us-gaap Interest Bearing Domestic Deposit Brokered
InterestBearingDomesticDepositBrokered
225415000
CY2019Q4 us-gaap Interest Bearing Domestic Deposit Brokered
InterestBearingDomesticDepositBrokered
229909000
CY2020Q1 us-gaap Interest Expense
InterestExpense
4399000
CY2019Q1 us-gaap Interest Expense
InterestExpense
4227000
CY2020Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
3200000
CY2019Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
3264000
CY2020Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
697000
CY2019Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
439000
CY2020Q1 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
268000
CY2019Q1 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
289000
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
5519000
CY2019Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6193000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6323000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6358000
CY2020Q1 us-gaap Interest Income Operating
InterestIncomeOperating
416000
CY2019Q1 us-gaap Interest Income Operating
InterestIncomeOperating
379000
CY2020Q1 us-gaap Interest Income Other Domestic Deposits
InterestIncomeOtherDomesticDeposits
135000
CY2019Q1 us-gaap Interest Income Other Domestic Deposits
InterestIncomeOtherDomesticDeposits
333000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
4781000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
3950000
CY2020Q1 us-gaap Investments
Investments
49280000
CY2019Q4 us-gaap Investments
Investments
52767000
CY2020Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
8104000
CY2019Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
8102000
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3861000
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3184000
CY2020Q1 us-gaap Liabilities
Liabilities
934956000
CY2019Q4 us-gaap Liabilities
Liabilities
912842000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
999579000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
979836000
CY2020Q1 us-gaap Loan Processing Fee
LoanProcessingFee
24000
CY2019Q1 us-gaap Loan Processing Fee
LoanProcessingFee
14000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
10115000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
10916000
CY2018Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7609000
CY2019Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7823000
CY2020Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
818841000
CY2020Q1 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0
CY2019Q4 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0
CY2020Q1 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
191000
CY2019Q1 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
275000
CY2020Q1 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
17996000
CY2019Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
15282000
CY2020Q1 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
18000000
CY2019Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
15300000
CY2020Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
147000
CY2019Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
115000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22585000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1552000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5520000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8688000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4313000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
435000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1072000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
323000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1072000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
323000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1072000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
323000
CY2020Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
83583000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
88135000
CY2020Q1 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
83583000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
88135000
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
7371000
CY2019Q1 us-gaap Noninterest Expense
NoninterestExpense
6448000
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
421000
CY2019Q1 us-gaap Noninterest Income
NoninterestIncome
746000
CY2020Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
111000
CY2019Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
95000
CY2020Q1 us-gaap Notes Payable To Bank
NotesPayableToBank
1143000
CY2019Q4 us-gaap Notes Payable To Bank
NotesPayableToBank
1193000
CY2020Q1 us-gaap Notes Receivable Net
NotesReceivableNet
807925000
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
802049000
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
949000
CY2019Q1 us-gaap Occupancy Net
OccupancyNet
917000
CY2020Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
131000
CY2019Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
130000
CY2020Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
8227000
CY2019Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
8726000
CY2020Q1 us-gaap Other Investments
OtherInvestments
4450000
CY2019Q4 us-gaap Other Investments
OtherInvestments
4450000
CY2020Q1 us-gaap Other Real Estate
OtherRealEstate
2400000
CY2019Q4 us-gaap Other Real Estate
OtherRealEstate
2400000
CY2020Q1 us-gaap Other Assets
OtherAssets
10634000
CY2019Q4 us-gaap Other Assets
OtherAssets
9526000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1342000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1808000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-15000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-466000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-3000
CY2020Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
492000
CY2019Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
569000
CY2020Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2020Q1 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2020Q1 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
CY2019Q1 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-415000
CY2020Q1 us-gaap Payments For Proceeds From Federal Reserve Bank Stock
PaymentsForProceedsFromFederalReserveBankStock
CY2019Q1 us-gaap Payments For Proceeds From Federal Reserve Bank Stock
PaymentsForProceedsFromFederalReserveBankStock
26000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
CY2019Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1396000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0
CY2020Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
19025000
CY2019Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
4804000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2020Q1 us-gaap Proceeds From Sale Of Other Loans Held For Sale
ProceedsFromSaleOfOtherLoansHeldForSale
144000
CY2019Q1 us-gaap Proceeds From Sale Of Other Loans Held For Sale
ProceedsFromSaleOfOtherLoansHeldForSale
5288000
CY2020Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
784000
CY2019Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
709000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34312000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34568000
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
804000
CY2019Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
165000
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
804000
CY2019Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
165000
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000
CY2019Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
49000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39845000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38773000
CY2020Q1 us-gaap Senior Notes
SeniorNotes
11871000
CY2019Q4 us-gaap Senior Notes
SeniorNotes
11853000
CY2020Q1 us-gaap Servicing Asset
ServicingAsset
198000
CY2019Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
201000
CY2018Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
37000
CY2020Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
198000
CY2019Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
99000
CY2020Q1 us-gaap Servicing Asset At Amortized Value Additions
ServicingAssetAtAmortizedValueAdditions
2000
CY2019Q1 us-gaap Servicing Asset At Amortized Value Additions
ServicingAssetAtAmortizedValueAdditions
66000
CY2020Q1 us-gaap Servicing Asset At Amortized Value Amortization1
ServicingAssetAtAmortizedValueAmortization1
5000
CY2019Q1 us-gaap Servicing Asset At Amortized Value Amortization1
ServicingAssetAtAmortizedValueAmortization1
4000
CY2020Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
272000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
43000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
48000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
48000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
64623000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
66994000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
69340000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
69649000
CY2020Q1 us-gaap Subordinated Debt
SubordinatedDebt
9760000
CY2019Q4 us-gaap Subordinated Debt
SubordinatedDebt
9752000
CY2020Q1 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.09
CY2020Q1 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.08
CY2020Q1 us-gaap Time Deposit Maturities Remainder Of Fiscal Year
TimeDepositMaturitiesRemainderOfFiscalYear
459350000
CY2020Q1 us-gaap Time Deposit Maturities Year Five
TimeDepositMaturitiesYearFive
1463000
CY2020Q1 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
895000
CY2020Q1 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
4440000
CY2020Q1 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
33022000
CY2020Q1 us-gaap Time Deposits
TimeDeposits
499170000
CY2020Q1 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
68444000
CY2019Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
67550000
CY2020Q1 us-gaap Transfer Of Loans Held For Sale To Portfolio Loans1
TransferOfLoansHeldForSaleToPortfolioLoans1
280000
CY2019Q1 us-gaap Transfer Of Loans Held For Sale To Portfolio Loans1
TransferOfLoansHeldForSaleToPortfolioLoans1
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3931388
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3917312
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3931388
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3917312

Files In Submission

Name View Source Status
0001437749-20-012633-index-headers.html Edgar Link pending
0001437749-20-012633-index.html Edgar Link pending
0001437749-20-012633.txt Edgar Link pending
0001437749-20-012633-xbrl.zip Edgar Link pending
ex_188043.htm Edgar Link pending
ex_188044.htm Edgar Link pending
ex_188045.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pnbk-20200331.xml Edgar Link completed
pnbk-20200331.xsd Edgar Link pending
pnbk-20200331_cal.xml Edgar Link unprocessable
pnbk-20200331_def.xml Edgar Link unprocessable
pnbk-20200331_lab.xml Edgar Link unprocessable
pnbk-20200331_pre.xml Edgar Link unprocessable
pnbk20200331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending